Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Health Law Mar 2020 Which Legal Approaches Help Limit Harms to Patients From Clinicians’ Conscience-Based Refusals? Rachel Kogan, JD, Katherine L. Kraschel, JD, and Claudia E. Haupt, PhD, JSD When a clinician refuses to do a procedure consistent with standard of care for a patient, legal resources can be helpful. AMA J Ethics. 2020;22(3):E209-216. doi: 10.1001/amajethics.2020.209. Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020;22(3):E239-247. doi: 10.1001/amajethics.2020.239. Case and Commentary Mar 2016 Ethical Challenges for the Medical Expert Witness Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Medical expert witnesses are ethically and legally obligated to provide honest testimony that meets the standards of the Daubert test. AMA J Ethics. 2016;18(3):201-208. doi: 10.1001/journalofethics.2016.18.3.ecas1-1603. Podcast Nov 2021 Author Interview: “Should Employment Division v Smith Be Overturned?” Dr Jake Greenblum joins Ethics Talk to discuss his article, coauthored with Dr Ryan Hubbard: “Should Employment Division v Smith Be Overturned?” Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Health Law Mar 2020 Which Legal Approaches Help Limit Harms to Patients From Clinicians’ Conscience-Based Refusals? Rachel Kogan, JD, Katherine L. Kraschel, JD, and Claudia E. Haupt, PhD, JSD When a clinician refuses to do a procedure consistent with standard of care for a patient, legal resources can be helpful. AMA J Ethics. 2020;22(3):E209-216. doi: 10.1001/amajethics.2020.209.
Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020;22(3):E239-247. doi: 10.1001/amajethics.2020.239.
Case and Commentary Mar 2016 Ethical Challenges for the Medical Expert Witness Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Medical expert witnesses are ethically and legally obligated to provide honest testimony that meets the standards of the Daubert test. AMA J Ethics. 2016;18(3):201-208. doi: 10.1001/journalofethics.2016.18.3.ecas1-1603.
Podcast Nov 2021 Author Interview: “Should Employment Division v Smith Be Overturned?” Dr Jake Greenblum joins Ethics Talk to discuss his article, coauthored with Dr Ryan Hubbard: “Should Employment Division v Smith Be Overturned?”
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.